Natera (MEX:NTRA) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:NTRA Natera Inc MEX:NTRA
60 GF Score
Price MXN3,905.00
GF Value MXN2,983.49
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Natera Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MEX:NTRA vs WAT, A, IQV: Short Interest Comparison

For the Diagnostics & Research subindustry, Natera's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natera Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Natera's Short Interest distribution charts can be found below:

* The bar in red indicates where Natera's Short Interest falls into.


MEX:NTRA
60GF Score
Natera Inc MEX:NTRA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Natera (MEX:NTRA) Overvalued in 2026?

Based on GuruFocus' analysis, Natera stock appears to be overvalued. The current stock price of MXN3,905.00 is trading 30.9% above its estimated GF Value™ of MXN2,983.49. GuruFocus considers Natera to be Significantly Overvalued.

Key valuation signals for MEX:NTRA:

  • Short Interest:
  • GF Value™: MXN2,983.49 vs. price of MXN3,905.00 (30.9% above fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the MEX:NTRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Natera Business Description

Other Exchanges NTRA:USA45E:Germany
Address 13011 McCallen Pass, Building A Suite 100, Austin, TX, USA, 78753
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
60GF Score

Get the complete analysis for MEX:NTRA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,905.00
Price
MXN2,983.49
GF Value